Pharmia
Pharmia Oy is a Finnish B2B contract manufacturer of food supplements and CE-marked medical devices, serving brand owners and pharmaceutical companies with product development, formulation, manufacturing, packaging and regulatory services from its Tuusula facility.
- Company typePrivate
- Founded1993
- HeadquartersTuusula, Finland
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Pharmia does
Pharmia Oy is a Finnish contract manufacturer specializing in food supplements and CE-marked medical devices, headquartered in Tuusula, Finland. Founded in 1993 as Finland's first contract manufacturer for pharmaceuticals and food supplements, the company has developed over 2,000 products for customers and maintains a portfolio of more than 400 raw materials. Pharmia operates a single-site facility and holds ISO 13485, FSSC 22000 and HACCP certifications, and was among the first companies in Finland to achieve EU MDR 2017/745 medical device compliance in December 2022.
The company generates revenue through B2B contract manufacturing services for brand owners, retailers and pharmaceutical companies, spanning product development, raw material sourcing, formulation, production, packaging, quality assurance and regulatory support. Dosage forms include tablets, capsules, powders, liquids and soft capsules. Operations are organized around an "idea to product" service concept with new product lead times of approximately four months and repeat orders delivered within three months on EXW terms. Pharmia also operates a branded catalog under the Pharmia Labs sub-brand covering probiotics, vitamins, minerals, beauty supplements and melatonin products for private label and white label deployment.
Pharmia was acquired by Italy-based Labomar Group, backed by private equity firm Charterhouse, in October 2025 and now operates as a subsidiary within that group, expanding its commercial reach beyond Finland into broader European B2B nutraceutical and medical device channels. Prior to the Labomar transaction, Finnish private equity firm CapMan had been the main owner since 2021. The company reported 51-100 employees and does not publicly disclose revenue.
Pharmia firmographics
Firmographics- Name
- Pharmia
- Legal name
- Pharmia Oy
- Website
- https://pharmia.fi
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Pharmia Oy is a Finnish B2B contract manufacturer of food supplements and CE-marked medical devices, serving brand owners and pharmaceutical companies with product development, formulation, manufacturing, packaging and regulatory services from its Tuusula facility.
- Ownership category
- akta.pro rank
Pharmia industry classification
Industry- Product category
- Nutraceutical Contract Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Compounding Pharmacies (Sterile/Non-Sterile) (HLAFALAE)
- akta.pro secondary industries
- Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Specialty Pharmacies (Complex/High-Cost Therapies) (HLAFALAC)
Keywords
Where Pharmia is headquartered
LocationHeadquarters
- HQ city
- Tuusula
- HQ country
- Finland
- HQ region
- Europe
Offices1 record
Markets served
Pharmia business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Contract Manufacturing Services: Pharmia generates revenue through contract manufacturing of food supplements and medical devices for brand owners. Services include product development, formulation, manufacturing, packaging, and quality assurance. Manufacturing lead time for new products is four months, with repeat orders delivered within three months. Minimum order quantities and pricing are negotiated per customer. Delivery terms typically EXW (Ex Works) where customer arranges pickup.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Pharmia product offering
Product offeringCore offering
Pharmia is a Finnish contract manufacturer that produces food supplements and medical devices for brand owners. The company provides full-service manufacturing from product idea to finished, packaged, and quality-assured goods, covering formulation development, raw material sourcing, manufacturing, packaging, and quality control.
Product overview
Pharmia is a Finnish contract manufacturer specializing in food supplements and medical devices. The company offers a portfolio of branded products under the Pharmia Labs sub-brand, including probiotic supplements (ProLab series), beauty supplements (Keratin, Collagen, TUKI), vitamins (C Liposomal, D Chew/B Drop/Drop/K2 Drop, Multivitamin for Vegans), minerals (Magnesium+B6, Calcium+D3, Iodine), and melatonin products (Long, Fast, General). The medical device portfolio includes nasal care products (NoseOil Nasal Spray series), common cold treatments (Pyroglutamate Nasal Spray, Zinc Lozenges, Zinc Throat Spray), Dry Mouth Spray, and Dimethicone-Lactase Capsules. Beyond product sales, Pharmia provides contract manufacturing services including product development, raw materials sourcing, manufacturing, packaging, and quality control—operating under a 'from idea to product' service concept.
Differentiator
Problem solved
Functional benefit
Brands
- Pharmia Labs: Product brand for food supplements including probiotics, vitamins, minerals, and melatonin products.
Products and services
- Contract Manufacturing Services
- Product Development Services
- Raw Materials Sourcing
- Packaging Services
- Quality Control
- Pharmia Labs Food Supplement Portfolio
- Pharmia Labs Medical Device Portfolio
Quantifiable outcome
- Delivery time for newly launched products is 4 months
- +2 more outcomes
Companies that use Pharmia
Customer profileSegments3 records
Ideal customer profiles1 record
Pharmia technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Pharmia partnerships and signals
Strategic signalScale indicators5 records
Recent moves10 records
Expansion highlights4 records
Pharmia competitors and assessment
Company assessmentDirect peers
- Salus Haus: German manufacturer of food supplements and natural health products, including contract manufacturing for brand owners. Comparable in product category (nutraceuticals), dosage forms (drops, tablets, liquids), and regulatory positioning (EU MDR/FSSC compliance).
- Swiss Caps: Swiss-based contract manufacturer specializing in capsules and softgels for pharma and nutraceutical customers. Comparable in capsule manufacturing technology and European B2B CDMO model serving supplement brand owners.
- Hermes Arzneimittel: German pharmaceutical and supplement contract manufacturer offering brand development and manufacturing services. Comparable as a European mid-market CDMO with end-to-end product development capabilities for brand owners.
- Labomar Group: Italian CDMO specializing in food supplements, medical devices, and cosmetics. Pharmia is now a subsidiary of Labomar Group (acquired October 2025), making it the most directly comparable peer in product category, customer base (brand owners), and business model (contract manufacturing).
Regional players
- Bioglan: Australian pharmaceutical contract manufacturer with expanding European presence, producing supplements and OTC products for brand owners. Comparable in product category and CDMO business model, though operating primarily outside Pharmia's EU core geography.
Others
- Eurofins CDMO: European testing and CDMO services provider. Comparable as a contract development and manufacturing partner to pharma/consumer health companies, with overlap in quality testing, regulatory services, and supplement manufacturing capabilities across Europe.
- Glanbia Nutritionals: Global ingredient solutions and premix manufacturer serving supplement and functional food brands. Comparable as a B2B partner in the nutraceutical value chain with custom formulation and ingredient supply capabilities relevant to Pharmia's product development services.
Broad incumbents
- Catalent: Global CDMO offering development and manufacturing services across biologics, softgels, oral solids, and specialty formats. Comparable in the softgel, oral solid, and consumer health CDMO segments relevant to Pharmia's supplement portfolio.
- Recipharm: Swedish-headquartered CDMO serving pharma and consumer health customers across multiple dosage forms. Comparable in B2B contract manufacturing model, EU regulatory footprint, and broad product category coverage, though Recipharm operates at significantly larger scale.
- Aenova Group: German pharmaceutical contract manufacturer with strong European footprint across solid, semi-solid, and liquid dosage forms. Comparable as a broad European CDMO serving brand owners and pharma customers with multi-format manufacturing capabilities.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Pharmia social profiles
Digital presencePharmia compliance and trust
Trust signalCompliance4 records
Pharmia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharmia leadership team
Management profileNumber of profiles
Profiles2 records
Pharmia funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharmia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharmia
What does Pharmia do?
Pharmia is a Finnish contract manufacturer that produces food supplements and medical devices for brand owners. The company provides full-service manufacturing from product idea to finished, packaged, and quality-assured goods, covering formulation development, raw material sourcing, manufacturing, packaging, and quality control.
Is Pharmia a public or private company?
Pharmia is a private company. It is classified as corporate owned and is currently operating.
When was Pharmia founded?
Pharmia was founded in 1993. It employs 51 to 100 people.
Where is Pharmia based?
Pharmia is headquartered in Tuusula, Finland, in the Europe region.
How does Pharmia make money?
One revenue line is on record: contract Manufacturing Services.
Who are Pharmia's main competitors?
Direct peers on record are Salus Haus, Swiss Caps, Hermes Arzneimittel and Labomar Group. Bioglan is listed as a regional player. Others are Eurofins CDMO and Glanbia Nutritionals. Broad incumbents are Catalent, Recipharm and Aenova Group.
Does Pharmia have an API?
No public API is recorded for Pharmia.
What industry is Pharmia in?
Pharmia's product category is Nutraceutical Contract Manufacturing. Its primary akta.pro industry code is HLAFALAE, Compounding Pharmacies (Sterile/Non-Sterile), with a secondary code of HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant). Its NAICS code is 325412 and its SIC code is 2834.